Found 206 chains in Knotted chains table. Displaying 1 - 150. Applied filters: Probabilistic

Search results query: lyase/lyase inhibitor

Hide raw data panel 
#pdbid|chain|deposition date|is S/K-not|(slip)knot types;
      
  6ufd|A|2020-08-22|S|+3.1;
  6ufb|A|2020-08-22|S|+3.1;
  6ufc|A|2020-08-22|S|+3.1;
  6wq7|A|2020-08-06|K|+3.1;
  6wq4|A|2020-08-06|S|+3.1;
  6wq8|A|2020-08-06|S|+3.1;
  6wq9|A|2020-08-06|S|+3.1;
  6otk|A|2020-08-04|S|+3.1;
  6oto|A|2020-08-04|S|+3.1;
  6otm|A|2020-08-04|K|+3.1;
  6oti|A|2020-08-04|K|+3.1;
  6otq|A|2020-08-04|S|+3.1;
  6oub|A|2020-08-04|S|+3.1;
  6otp|A|2020-08-04|S|+3.1;
  6ouh|A|2020-08-04|S|+3.1;
  6oud|A|2020-08-04|S|+3.1;
  6ouf|A|2020-08-04|S|+3.1;
  6ouk|A|2020-08-04|S|+3.1;
  6oui|A|2020-08-04|S|+3.1;
  6ouj|A|2020-08-04|S|+3.1;
  6oum|A|2020-08-04|S|+3.1;
  6oue|A|2020-08-04|K|+3.1;
  6vj3|A|2020-04-02|K|+3.1;
  6vkg|A|2020-04-02|S|+3.1;
  6ugp|A|2020-03-31|S|+3.1;
  6ugq|A|2020-03-31|S|+3.1;
  6ugn|A|2020-03-31|K|+3.1;
  6ugr|A|2020-03-31|S|+3.1;
  6ugz|A|2020-03-31|S|+3.1;
  6ugo|A|2020-03-31|S|+3.1;
  6uh0|A|2020-03-31|S|+3.1;
  6u4q|A|2020-01-29|S|+3.1;
  6u4t|A|2020-01-29|S|+3.1;
  6nm0|A|2020-01-22|S|+3.1;
  6nlv|A|2020-01-22|S|+3.1;
  6eeo|A|2018-12-02|S|+3.1;
  6eda|A|2018-12-02|K|+3.1;
  6eeh|A|2018-12-02|S|+3.1;
  6eea|A|2018-12-02|K|+3.1;
  6ebe|A|2018-12-02|S|+3.1;
  5thi|A|2018-10-25|S|+3.1;
  4qsj|A|2018-10-21|S|+3.1;
  4qiz|A|2018-10-21|S|+3.1;
  5eij|A|2018-10-20|K|+3.1;
  4mdg|A|2018-10-20|K|+3.1;
  4qj0|A|2018-10-20|S|+3.1;
  4m2r|A|2018-10-20|K|+3.1;
  3mna|A|2018-10-20|S|+3.1;
  4knj|A|2018-10-20|S|+3.1;
  4qsb|A|2018-10-20|K|+3.1;
  3mzc|A|2018-10-20|S|+3.1;
  4q09|A|2018-10-20|S|+3.1;
  4e3h|A|2018-10-20|S|+3.1;
  4m2w|A|2018-10-20|S|+3.1;
  4q08|A|2018-10-20|S|+3.1;
  4mdl|A|2018-10-20|K|+3.1;
  4q07|A|2018-10-20|S|+3.1;
  4fpt|A|2018-10-20|K|+3.1;
  3ieo|A|2018-10-20|S|+3.1;
  3nj9|A|2018-10-20|S|+3.1;
  5ekh|A|2018-10-20|S|+3.1;
  4rn4|A|2018-10-20|S|+3.1;
  4pq7|A|2018-10-20|S|+3.1;
  4kp5|A|2018-10-20|K|+3.1;
  5tfx|A|2018-10-20|K|+3.1;
  4mty|A|2018-10-20|S|+3.1;
  5th4|A|2018-10-20|K|+3.1;
  4zwz|A|2018-10-20|S|+3.1;
  5sz5|A|2018-10-20|K|+3.1;
  4pyy|A|2018-10-20|S|+3.1;
  4dz7|A|2018-10-19|S|+3.1;
  4kp8|A|2018-10-19|K|+3.1;
  4jss|A|2018-10-19|S|+3.1;
  4q6d|A|2018-10-19|S|+3.1;
  4lhi|A|2018-10-19|S|+3.1;
  3oyq|A|2018-10-19|S|+3.1;
  4frc|A|2018-10-19|S|+3.1;
  4pxx|A|2018-10-19|S|+3.1;
  4e3d|A|2018-10-19|S|+3.1;
  3n2p|A|2018-10-19|S|+3.1;
  3t5z|A|2018-10-19|S|+3.1;
  4m2u|A|2018-10-19|K|+3.1;
  3s9t|A|2018-10-19|S|+3.1;
  6bcc|A|2018-10-19|S|+3.1;
  5ti0|A|2018-10-19|S|+3.1;
  5jn7|A|2018-10-19|S|+3.1;
  4qjw|A|2018-10-19|S|+3.1;
  4qsi|A|2018-10-19|S|+3.1;
  3sap|A|2018-10-19|S|+3.1;
  4iwz|A|2018-10-19|K|+3.1;
  4qtl|A|2018-10-19|S|+3.1;
  4ht2|A|2018-10-19|K|+3.1;
  3v7x|A|2018-10-19|K|+3.1;
  4kni|A|2018-10-19|S|+3.1;
  3sbh|A|2018-10-19|S|+3.1;
  4qjm|A|2018-10-19|K|+3.1;
  5jn1|A|2018-10-19|S|+3.1;
  6bbs|A|2018-10-19|K|+3.1;
  3mmf|A|2018-10-19|S|+3.1;
  4mdm|A|2018-10-19|K|+3.1;
  3n0n|A|2018-10-19|K|+3.1;
  4mo8|A|2018-10-19|S|+3.1;
  5vgy|A|2018-10-19|K|+3.1;
  4qy3|A|2018-10-19|S|+3.1;
  4g0c|A|2018-10-19|S|+3.1;
  4zx1|A|2018-10-19|S|+3.1;
  4kuy|A|2018-10-19|K|+3.1;
  4ito|A|2018-10-19|S|+3.1;
  4ilx|A|2018-10-19|S|+3.1;
  4pyx|A|2018-10-19|K|+3.1;
  3qyk|A|2018-10-19|S|+3.1;
  4q78|A|2018-10-19|S|+3.1;
  4e4a|A|2018-10-19|K|+3.1;
  4jsa|A|2018-10-19|S|+3.1;
  3ni5|A|2018-10-19|S|+3.1;
  4fvn|A|2018-10-19|S|+3.1;
  5jmz|A|2018-10-19|S|+3.1;
  6d1l|A|2018-10-19|K|+3.1;
  3vbd|A|2018-10-19|K|+3.1;
  4hu1|A|2018-10-19|S|+3.1;
  5tuo|A|2018-10-19|K|+3.1;
  3t82|A|2018-10-19|S|+3.1;
  4jsz|A|2018-10-19|S|+3.1;
  4e3f|A|2018-10-19|K|+3.1;
  3m2y|A|2018-10-18|S|+3.1;
  3rj7|A|2018-10-18|S|+3.1;
  3k34|A|2018-10-18|K|+3.1;
  4e3g|A|2018-10-18|K|+3.1;
  5ekj|A|2018-10-18|S|+3.1;
  4zwi|A|2018-10-18|S|+3.1;
  4zwy|A|2018-10-18|S|+3.1;
  4jsw|A|2018-10-18|S|+3.1;
  3t83|A|2018-10-18|S|+3.1;
  3p4v|A|2018-10-18|S|+3.1;
  3ml2|A|2018-10-18|K|+3.1;
  4m2v|A|2018-10-18|S|+3.1;
  4qef|A|2018-10-18|K|+3.1;
  6d1m|A|2018-10-18|S|+3.1;
  5wex|A|2018-10-18|K|+3.1;
  4zwx|A|2018-10-18|S|+3.1;
  4riu|A|2018-10-18|S|+3.1;
  4q06|A|2018-10-18|K|+3.1;
  6bc9|A|2018-10-18|S|+3.1;
  5ekm|A|2018-10-18|K|+3.1;
  4zx0|A|2018-10-18|S|+3.1;
  3oys|A|2018-10-18|K|+3.1;
  4q0l|A|2018-10-18|S|+3.1;
  4itp|A|2018-10-18|K|+3.1;
  3t84|A|2018-10-18|S|+3.1;
  3oy0|A|2018-10-18|S|+3.1;
  4qjx|A|2018-10-17|S|+3.1;
  4knm|A|2018-10-17|S|+3.1;
  4lp6|A|2018-10-17|S|+3.1;
  4knn|A|2018-10-17|K|+3.1;
  4kuw|A|2018-10-17|S|+3.1;
  3n4b|A|2018-10-17|S|+3.1;
  3sax|A|2018-10-17|K|+3.1;
  4qsa|A|2018-10-17|K|+3.1;
  4qiy|A|2018-10-17|S|+3.1;
  4pzh|A|2018-10-17|S|+3.1;
  4q6e|A|2018-10-17|S|+3.1;
  3s8x|A|2018-10-17|K|+3.1;
  4ht0|A|2018-10-17|S|+3.1;
  5thn|A|2018-10-17|S|+3.1;
  3n3j|A|2018-10-17|S|+3.1;
  4fu5|A|2018-10-03|S|+3.1;
  4kv0|A|2018-10-03|S|+3.1;
  4fvo|A|2018-10-03|S|+3.1;
  4qjo|A|2018-10-03|S|+3.1;
  4qjp|A|2018-10-03|S|+3.1;
  4kuv|A|2018-10-03|S|+3.1;
  5sz6|A|2018-10-03|S|+3.1;
  4e49|A|2018-10-03|S|+3.1;
  4lu3|A|2018-10-03|K|+3.1;
  3t85|A|2018-10-02|K|+3.1;
  3v5g|A|2018-10-01|S|+3.1;
  3sbi|A|2018-10-01|K|+3.1;
  3pyk|A|2018-09-28|S|+3.1;
  3mhl|A|2018-09-12|K|+3.1;
  3m5e|A|2018-09-12|K|+3.1;
  3m40|A|2018-09-12|K|+3.1;
  3m3x|A|2018-09-12|K|+3.1;
  3m67|A|2018-09-12|K|+3.1;
  3mho|A|2018-09-12|S|+3.1;
  3mhi|A|2018-09-12|S|+3.1;
  3m2n|A|2018-09-12|K|+3.1;
  3mhm|A|2018-09-12|K|+3.1;
  3po6|A|2018-09-12|K|+3.1;
  3ibu|A|2018-09-12|K|+3.1;
  3ibi|A|2018-09-12|S|+3.1;
  3ibn|A|2018-09-12|K|+3.1;
  3ibl|A|2018-09-12|K|+3.1;
  5tv3|A|2017-09-20|K|+3.1;
  5ku6|A|2017-08-28|K|+3.1;
  5jnc|A|2017-05-04|K|+3.1;
  5thj|A|2017-05-03|K|+3.1;
  5jn8|A|2017-05-03|K|+3.1;
  5jna|A|2017-05-03|K|+3.1;
  5jn3|A|2017-05-03|K|+3.1;
  5sz7|A|2017-02-06|K|+3.1;
  5sz0|A|2017-02-05|K|+3.1;
  5sz1|A|2017-02-05|K|+3.1;
  5sz2|A|2017-02-05|K|+3.1;
  5sz3|A|2017-02-05|K|+3.1;
  5sz4|A|2017-02-05|K|+3.1;
  5cjl|A|2016-09-28|K|+3.1;
Knot types Knot loop types pdb Title
S +31 S 3x +31 6ufdA Carbonic anhydrase 2 with inhibitor (2z)-3-oxo-n-(4-sulfamoylphenyl)-2-[(thiophen-2-yl)methylidene]butanamide (11g/d7)
S +31 S 3x +31 6ufbA Carbonic anhydrase 2 with inhibitor (2z)-2-benzylidene-3-oxo-n-(4-sulfamoylphenyl)butanamide (11a/d1)
S +31 S 3x +31 6ufcA Carbonic anhydrase 2 with inhibitor (2z)-2-[(4-methoxyphenyl)methylidene]-3-oxo-n-(4-sulfamoylphenyl)butanamide (11d/d4)
K +31 K 3x +31 6wq7A Carbonic anhydrase ii complexed with 2-((3-aminopropyl)(phenethyl)amino)-n-(4-fluorobenzyl)-n-(4-sulfamoylphenethyl)acetamide
S +31 S 3x +31 6wq4A Carbonic anhydrase ii complexed with 2-((2-cyanoethyl)(phenethyl)amino)-n-phenethyl-n-(4-sulfamoylphenethyl)acetamide
S +31 S 3x +31 6wq8A Carbonic anhydrase ii complexed with 3-((2-((furan-2-ylmethyl)(4-sulfamoylphenethyl)amino)-2-oxoethyl)(phenethyl)amino)propanoic acid
S +31 S 3x +31 6wq9A Carbonic anhydrase ii complexed with 3-((2-((naphthalen-2-ylmethyl)(4-sulfamoylphenethyl)amino)-2-oxoethyl)(phenethyl)amino)propanoic acid
S +31 S 3x +31 6otkA Carbonic anhydrase ix mimic complexed with ureido benzene sulfonamide mb10-596b
S +31 S 3x +31 6otoA Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb9-561b
K +31 K 3x +31 6otmA Carbonic anhydrase ix mimic complexed with ureic benzene sulfonamide mb10-586b
K +31 K 3x +31 6otiA Carbonic anhydrase ix mimic complexed with ureic benzene sulfonamide mb9-561b
S +31 S 3x +31 6otqA Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb10-596b
S +31 S 3x +31 6oubA Carbonic anhydrase ii complexed with benzene sulfonamide mb11-694b
S +31 S 3x +31 6otpA Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb10-586b
S +31 S 3x +31 6ouhA Carbonic anhydrase ii mimic complexed with benzene sulfonamide mb11-710a
S +31 S 3x +31 6oudA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb11-694b
S +31 S 3x +31 6oufA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb11-707a
S +31 S 3x +31 6oukA Carbonic anhydrase ii complexed with benzene sulfonamide mb10-580b
S +31 S 3x +31 6ouiA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb11-710a
S +31 S 3x +31 6oujA Carbonic anhydrase ii complexed with benzene sulfonamide mb11-689a
S +31 S 3x +31 6oumA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb10-580b
K +31 K 3x +31 6oueA Carbonic anhydrase ii complexed with benzene sulfonamide mb11-707a
K +31 K 3x +31 6vj3A Carbonic anhydrase ii in complex with pyrimidine-based inhibitor
S +31 S 3x +31 6vkgA Human carbonic anhydrase ix mimic with epacadostat bound
S +31 S 3x +31 6ugpA Human carbonic anhydrase 2 complexed with sb4-206
S +31 S 3x +31 6ugqA Human carbonic anhydrase ix-mimic complexed with sb4-206
K +31 K 3x +31 6ugnA Human carbonic anhydrase 2 complexed with sb4-205
S +31 S 3x +31 6ugrA Human carbonic anhydrase 2 complexed with sb4-208
S +31 S 3x +31 6ugzA Human carbonic anhydrase ix-mimic complexed with sb4-208
S +31 S 3x +31 6ugoA Human carbonic anhydrase ix-mimic complexed with sb4-205
S +31 S 3x +31 6uh0A Human carbonic anhydrase 2 in complex with sb4-202
S +31 S 3x +31 6u4qA Carbonic anhydrase 2 in complex with sb4197
S +31 S 3x +31 6u4tA Carbonic anhydrase 9 in complex with sb4197
S +31 S 3x +31 6nm0A Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines
S +31 S 3x +31 6nlvA Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines
S +31 S 3x +31 6eeoA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
K +31 K 3x +31 6edaA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
S +31 S 3x +31 6eehA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
K +31 K 3x +31 6eeaA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
S +31 S 3x +31 6ebeA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
S +31 S 7x +31 5thiA Crystal structure of 2-hydroxycyclohepta-2,4,6-trien-1-one bound to human carbonic anhydrase 2 l198g
S +31 S 3x +31 4qsjA Crystal structure of human carbonic anhydrase isozyme xiii with 2-chloro-4-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide
S +31 S 3x +31 4qizA Crystal structure of human carbonic anhydrase isozyme xiii with inhibitor
K +31 K 3x +31 5eijA Carbonic anhydrase ii in complex with sulfonamide inhibitor
K +31 K 3x +31 4mdgA Closo carborane carbonic anhydrase inhibitor
S +31 S 3x +31 4qj0A Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with inhibitor
K +31 K 3x +31 4m2rA Human carbonic anhydrase ii in complex with brinzolamide
S +31 S 3x +31 3mnaA The crystal structure of human carbonic anhydrase ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor
S +31 S 3x +31 4knjA Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide
K +31 K 3x +31 4qsbA Crystal structure of human carbonic anhydrase isozyme ii with 3-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide
S +31 S 3x +31 3mzcA Human carbonic ahydrase ii in complex with a benzenesulfonamide inhibitor
S +31 S 3x +31 4q09A Crystal structure of chimeric carbonic anhydrase xii with inhibitor
S +31 S 3x +31 4e3hA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
S +31 S 3x +31 4m2wA Genetically engineered carbonic anhydrase ix in complex with dorzolamide
S +31 S 3x +31 4q08A Crystal structure of chimeric carbonic anhydrase xii with inhibitor
K +31 K 11x +31 4mdlA Meta carborane carbonic anhydrase inhibitor
S +31 S 3x +31 4q07A Crystal structure of chimeric carbonic anhydrase ix with inhibitor
K +31 K 11x +31 4fptA Carbonic anhydrase ii in complex with ethyl (2z,4r)-2-(sulfamoylimino)-1,3-thiazolidine-4-carboxylate
S +31 S 6x +31 3ieoA The coumarin-binding site in carbonic anhydrase: the antiepileptic lacosamide as an example
S +31 S 11x +31 3nj9A Crystal structure of carbonic anhydrase ii in complex with a nir inhibitor
S +31 S 3x +31 5ekhA Human carbonic anhydrase ii complexed with a two-faced guest
S +31 S 3x +31 4rn4A Human carbonic anhydrases ii in complex with a acetazolamide derivative comprising one hydrophobic and one hydrophilic tail moiety
S +31 S 3x +31 4pq7A The crystal structure of the human carbonic anhydrase ii in complex with a sulfamide inhibitor
K +31 K 3x +31 4kp5A Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with 2-chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide
K +31 K 3x +31 5tfxA New method for synthesis of benzoxazole amide inhibitors of carbonic anhydrase
S +31 S 15x +31 4mtyA Structure at 1a resolution of a helical aromatic foldamer-protein complex.
K +31 K 3x +31 5th4A Crystal structure of 1-hydroxypyridine-2(1h)-thione bound to human carbonic anhydrase 2 l198g
S +31 S 3x +31 4zwzA Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor
K +31 K 3x +31 5sz5A Carbonic anhydrase ix-mimic in complex with 4-(2-methylphenyl)-benzenesulfonamide
S +31 S 3x +31 4pyyA Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
S +31 S 3x +31 4dz7A Hca ii in complex with novel sulfonamide inhibitors set d
K +31 K 3x +31 4kp8A Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with 3-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide
S +31 S 11x +31 4jssA Human carbonic anhydrase ii h94d bound to a bidentate inhibitor
S +31 S 3x +31 4q6dA Crystal structure of human carbonic anhydrase isozyme ii with 4-[(z)-azepan-1-yldiazenyl]benzenesulfonamide
S +31 S 3x +31 4lhiA Crystal structure of human carbonic anhydrase isozyme ii with 5-(phenylsulfonyl)thiophene-2-sulfonamide
S +31 S 3x +31 3oyqA Structure of human carbonic anhydrase ii complexed with 5,6-dihydro-benzo[h]cinnolin-3-ylamine
S +31 S 23x +31 4frcA Carbonic anhydrase ii in complex with n'-sulfamoylpyrrolidine-1-carboximidamide
S +31 S 3x +31 4pxxA Crystal structure of a highly thermal stabilized variant of human carbonic anhydrase ii
S +31 S 3x +31 4e3dA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
S +31 S 3x +31 3n2pA Crystal structure of human carbonic anhydrase ii in complex with a benzenesulfonamide inhibitor
S +31 S 3x +31 3t5zA Crystal structure of the human carbonic anhydrase ii in complex with n-methoxy-benzenesulfonamide
K +31 K 3x +31 4m2uA Carbonic anhydrase ii in complex with dorzolamide
S +31 S 3x +31 3s9tA Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-5-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
S +31 S 3x +31 6bccA Joint x-ray/neutron structure of human carbonic anhydrase ii in complex with ethoxzolamide
S +31 S 3x +31 5ti0A Crystal structure of 2-hydroxycyclohepta-2,4,6-triene-1-thione bound to human carbonic anhydrase 2 l198g
S +31 S 3x +31 5jn7A Carbonic anhydrase ii in complex with u-ch3
S +31 S 3x +31 4qjwA Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with inhibitor
S +31 S 3x +31 4qsiA Crystal structure of human carbonic anhydrase isozyme ii with 5-{[(4-tert-buthyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}-2-chlorobenzenesulfonamide
S +31 S 3x +31 3sapA Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(5-butyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
K +31 K 3x +31 4iwzA Structure of hcaii in complex with an acetazolamide derivative
S +31 S 3x +31 4qtlA Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
K +31 K 3x +31 4ht2A Crystal structure of human carbonic anhydrase isozyme xii with the inhibitor.
K +31 K 3x +31 3v7xA Complex of human carbonic anhydrase ii with n-[2-(3,4-dimethoxyphenyl)ethyl]-4-sulfamoylbenzamide
S +31 S 3x +31 4kniA Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-4-{[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetyl}benzenesulfonamide
S +31 S 3x +31 3sbhA Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
K +31 K 3x +31 4qjmA Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
S +31 S 3x +31 5jn1A Carbonic anhydrase ix-mimic in complex with u-ch3
K +31 K 3x +31 6bbsA Joint x-ray/neutron structure of human carbonic anhydrase ii in complex with brinzolamide
S +31 S 3x +31 3mmfA Crystal structure of human carbonic anhydrase ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor
K +31 K 3x +31 4mdmA Nido-carborane carbonic anhydrase inhibitor
K +31 K 3x +31 3n0nA Crystal structure of human carbonic anhydrase ii in complex with a benzenesulfonamide inhibitor
S +31 S 3x +31 4mo8A The crystal structure of the human carbonic anhydrase ii in complex with n-[2-(2-methyl-5-nitro-1h-imidazol-1-yl)ethyl]sulfamide
K +31 K 4x +31 5vgyA Identification of a new zinc binding chemotype by fragment screening
S +31 S 11x +31 4qy3A The crystal structure of the complex of hcaii with an ortho-substituted benzoic acid
S +31 S 3x +31 4g0cA Neutron structure of acetazolamide-bound human carbonic anhydrase ii reveal molecular details of drug binding.
S +31 S 3x +31 4zx1A Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor
K +31 K 3x +31 4kuyA Crystal structure of human carbonic anhydrase ii in complex with the 5-(3-(o-tolylsulfonyl)ureido)pyridine-2-sulfonamide inhibitor
S +31 S 3x +31 4itoA Human ca ii inhibition by novel sulfonamide
S +31 S 3x +31 4ilxA Structure of human carbonic anhydrase ii in complex with an adamantyl sulfonamide inhibitor
K +31 K 3x +31 4pyxA Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
S +31 S 3x +31 3qykA Human carbonic anhydrase ii complexed with triple ring benzene sulfonamide inhibitor
S +31 S 7x +31 4q78A Structure-assisted design of carborane-based inhibitors of carbonic anhydrase
K +31 K 3x +31 4e4aA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
S +31 S 23x +31 4jsaA Benzenesulfonamide complexed with hcaii h94d
S +31 S 3x +31 3ni5A Carbonic anhydrase inhibitor: c1 family
S +31 S 11x +31 4fvnA Carbonic anhydrase ii in complex with n-(tetrahydropyrimidin-2(1h)-ylidene)sulfuric diamide
S +31 S 3x +31 5jmzA Carbonic anhydrase ix-mimic in complex with u-no2
K +31 K 3x +31 6d1lA Design, synthesis, and x-ray of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects
K +31 K 3x +31 3vbdA Complex of human carbonic anhydrase ii with 4-(6-methoxy-3,4-dihydroisoquinolin-1-yl)benzenesulfonamide
S +31 S 3x +31 4hu1A Crystal structure of human carbonic anhydrase isozyme xiii with the inhibitor.
K +31 K 3x +31
4
5tuoA Crystal structure of the complex of helicobacter pylori alpha-carbonic anhydrase with 5-amino-1,3,4-thiadiazole-2-sulfonamide inhibitor.
S +31 S 3x +31 3t82A Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates
S +31 S 3x +31 4jszA Benzenesulfonamide bound to hcaii h94c
K +31 K 3x +31 4e3fA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
S +31 S 7x +31 3m2yA Carbonic anhydrase ii in complex with novel sulfonamide inhibitor
S +31 S 23x +31 3rj7A Human carbonic anhydrase ii complexed with its inhibitor rhenium(i)triscarbonyl-cyclopentadienyl-carboxy-4-aminomethylbenzene-sulfonamide
K +31 K 11x +31 3k34A Human carbonic anhydrase ii with a sulfonamide inhibitor
K +31 K 3x +31 4e3gA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
S +31 S 3x +31 5ekjA Human carbonic anhydrase ii complexed with a two-faced guest
S +31 S 3x +31
4
4zwiA Surface lysine acetylated human carbonic anhydrase ii in complex with a sulfamate-based inhibitor
S +31 S 3x +31 4zwyA Human carbonic anhydrase ii in complex with a glucosyl sulfamate inhibitor
S +31 S 3x +31 4jswA Human carbonic anhydrase ii h94c
S +31 S 3x +31 3t83A Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates
S +31 S 3x +31 3p4vA Human carbonic anhydrase ii in complex with (+)-xylariamide a
K +31 K 3x +31 3ml2A Human carbonic anhydsase ii in complex with an aryl sulfonamide inhibitor
S +31 S 3x +31 4m2vA Genetically engineered carbonic anhydrase ix in complex with brinzolamide
K +31 K 3x +31 4qefA Human carbonic anhydrase ii v207i - cyanate inhibitor complex
S +31 S 3x +31 6d1mA Design, synthesis, and x-ray of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects
K +31 K 3x +31 5wexA Discovery of new selenoureido analogs of 4-(4-fluorophenylureido) benzenesulfonamides as carbonic anhydrase inhibitors
S +31 S 3x +31 4zwxA Engineered carbonic anhydrase ix mimic in complex with glucosyl sulfamate inhibitor
S +31 S 3x +31 4riuA A carbonic anhydrase ix mimic in complex with a saccharin-based inhibitor
K +31 K 3x +31 4q06A Crystal structure of chimeric carbonic anhydrase ix with inhibitor
S +31 S 3x +31 6bc9A Joint x-ray/neutron structure of human carbonic anhydrase ii in complex with dorzolamide
K +31 K 3x +31 5ekmA Human carbonic anhydrase ii complexed with a two-faced guest
S +31 S 3x +31 4zx0A Human carbonic anhydrase ii in complex with a glucosyl sulfamate inhibitor
K +31 K 3x +31 3oysA Human carbonic anhydrase ii complexed with 2-{[4-amino-3-(3-hydroxyprop-1-yn-1-yl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]methyl}-5-methyl-3-(2-methylphenyl)quinazolin-4(3h)-one
S +31 S 3x +31 4q0lA Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with inhibitor
K +31 K 3x +31 4itpA Structure of human carbonic anhydrase ii bound to a benzene sulfonamide
S +31 S 3x +31 3t84A Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates
S +31 S 3x +31 3oy0A Human carbonic anhydrase ii complexed with 1-(4-(4-(2-(isopropylsulfonyl)phenylamino)-1h-pyrrolo[2,3-b]pyridin-6-ylamino)-3-methoxyphenyl)piperidin-4-ol
How to cite
KnotProt | Interdisciplinary Laboratory of Biological Systems Modelling